Hans Preusting

Co-Founder • DegenRx B.V

Hans Preusting has over 30 years of experience in the Life Science sector and previously served as Chief Business Officer and interim COO of uniQure. He is co-founder of two biotech start-up companies. One of them is DegenRx B.V., which was built based on his gene therapy experience at his time at uniQure. He holds two patents and has published over 20 scientific articles. His expertise is focused on business development, product development and manufacturing. He earned a PhD in biochemistry from the University of Groningen and an MBA from Rotterdam School of Management, The Netherlands. 

Also speaking

Olivier Negre

Chief Scientific Officer • Smart Immune

Ruud Das

Chief Scientific Officer • Scinus Cell Expansion Netherlands B.V

Robert Allen

Managing Partner, General Manager • Dark Horse Consulting Group

Event Info


Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.


Find out more about partnering at Advanced Therapies Europe.